Log in

NASDAQ:APMAptorum Group Stock Price, Forecast & News

+0.04 (+1.30 %)
(As of 06/3/2020 04:00 PM ET)
Today's Range
Now: $3.12
50-Day Range
MA: $3.27
52-Week Range
Now: $3.12
Volume27,500 shs
Average Volume24,403 shs
Market Capitalization$90.40 million
P/E RatioN/A
Dividend YieldN/A
Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The company also focuses on the development of surgical robotics and medical devices; and operating outpatient clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in Central, Hong Kong.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:APM



Sales & Book Value

Annual Sales$540,000.00
Book Value$0.51 per share



Market Cap$90.40 million
Next Earnings Date7/29/2020 (Estimated)
OptionableNot Optionable

Receive APM News and Ratings via Email

Sign-up to receive the latest news and ratings for APM and its competitors with MarketBeat's FREE daily newsletter.

Aptorum Group (NASDAQ:APM) Frequently Asked Questions

How has Aptorum Group's stock been impacted by COVID-19 (Coronavirus)?

Aptorum Group's stock was trading at $2.93 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, APM stock has increased by 6.5% and is now trading at $3.12. View which stocks have been most impacted by Coronavirus.

When is Aptorum Group's next earnings date?

Aptorum Group is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Aptorum Group.

Has Aptorum Group been receiving favorable news coverage?

News headlines about APM stock have been trending very negative on Thursday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Aptorum Group earned a news impact score of -3.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutAptorum Group.

Are investors shorting Aptorum Group?

Aptorum Group saw a decline in short interest in May. As of May 15th, there was short interest totaling 16,600 shares, a decline of 5.7% from the April 30th total of 17,600 shares. Based on an average daily trading volume, of 32,400 shares, the days-to-cover ratio is currently 0.5 days. Currently, 0.3% of the company's shares are short sold. View Aptorum Group's Current Options Chain.

Who are some of Aptorum Group's key competitors?

What other stocks do shareholders of Aptorum Group own?

Who are Aptorum Group's key executives?

Aptorum Group's management team includes the following people:
  • Mr. Chung Yuen Huen, Founder, CEO & Exec. Director (Age 39)
  • Mr. Darren Lui, Pres, Chief Bus. Officer & Exec. Director (Age 38)
  • Ms. Sabrina Khan, Chief Financial Officer (Age 37)
  • Dr. Siu-yan Ng, Chief Operating Officer (Age 38)
  • Mr. Clark Cheng, Chief Medical Officer & Exec. Director (Age 39)

What is Aptorum Group's stock symbol?

Aptorum Group trades on the NASDAQ under the ticker symbol "APM."

How do I buy shares of Aptorum Group?

Shares of APM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aptorum Group's stock price today?

One share of APM stock can currently be purchased for approximately $3.12.

How big of a company is Aptorum Group?

Aptorum Group has a market capitalization of $90.40 million and generates $540,000.00 in revenue each year. Aptorum Group employs 39 workers across the globe.

What is Aptorum Group's official website?

The official website for Aptorum Group is www.aptorumgroup.com.

How can I contact Aptorum Group?

Aptorum Group's mailing address is 17/F GUANGDONG INVESTMENT TOWER 148 CONNAUGHT ROAD CENTRAL, HONG KONG K3, 999077. The company can be reached via phone at 852-2117-6611 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.